ARCHIVES

Navelbine+Herceptin: 78% Response In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004

In Brief: Balch To Head City of Hope; Rowinsky Moves To San Antonio; Klausner’s Deputy Joins NCI

August 9, 1996

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991

Litton Awarded $342,618 For Frederick Fee

February 21, 1975

Concepts Approved For Developmental Therapeutics Program

June 19, 1987

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001